2025 annual financial data
Black Diamond Therapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was 42.31%.
Operating income was 19,870,000 USD and net income was 22,367,000 USD.
Operating cash flow was 29,614,000 USD.
Get free Black Diamond Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 70,000,000 USD
- Operating income
- 19,870,000 USD
- Net income
- 22,367,000 USD
- Operating cash flow
- 29,614,000 USD